Verano Holdings (VRNO) Change in Inventory (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Change in Inventory of $5.7 million for Q1 2026, down 32.36% year-over-year from $8.5 million in Q1 2025, and down 44.56% quarter-over-quarter from $10.4 million in Q4 2025.
Verano Holdings (VRNO) Change in Inventory (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Change in Inventory for 6 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 32.36% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $44.0 million (up 205.98% YoY), while the FY2025 annual figure was $46.8 million, up 194.29% from the prior year.
- Change in Inventory eased to $5.7 million in Q1 2026 per VRNO's latest filing, from $10.4 million in the prior quarter.
- Across five years, Change in Inventory topped out at $26.6 million in Q1 2022 and bottomed at -$10.9 million in Q1 2023.
- Historically, Change in Inventory has averaged $4.0 million across 5 years, with a median of $5.2 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 146.11% — and 2025, when it surged 528.22%.
- Verano Holdings' Change in Inventory stood at -$4.8 million in 2022, then tumbled by 104.95% to -$9.8 million in 2023, then surged by 75.22% to -$2.4 million in 2024, then soared by 528.22% to $10.4 million in 2025, then tumbled by 44.56% to $5.7 million in 2026.
- Business Quant data shows VRNO's Change in Inventory at $5.7 million in Q1 2026, $10.4 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn | -13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.18 Mn |
| Jun 30, 2026 | -13.18 Mn |
| Mar 31, 2026 | 5.75 Mn |
| Mar 31, 2026 | 5.75 Mn |
| Dec 31, 2025 | 10.36 Mn |
| Dec 31, 2025 | 10.36 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 22.72 Mn |
| Jun 30, 2025 | 22.72 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |